Rosalind Advisors, Inc.

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Femasys Inc 13G FEMY · 31447E204	FEMY	31447E204	9.9%	4,687,500	13G	8/14/2026 Event 8/10/2026
Rosalind Advisors, Inc.			9.9%	4,687,500
Salamon Steven A J			9.9%	4,687,500
Aharon Gil			9.9%	4,687,500
Rosalind Master Fund L.P.			9.9%	4,687,500
Regentis Biomaterials Ltd. 13G 001219096		001219096	9.9%	1,428,570	13G	8/13/2026 Event 6/30/2026
Rosalind Advisors, Inc.			9.9%	1,428,570
Salamon Steven A J			9.9%	1,428,570
Aharon Gil			9.9%	1,428,570
Rosalind Master Fund L.P.			9.9%	1,428,570
Fennec Pharmaceuticals Inc. 13G/A Amendment 3 FENC · 31447P100	FENC	31447P100	9.6%	3,321,333	13G/A Amendment 3	8/13/2026 Event 6/30/2026
Rosalind Advisors, Inc.			9.6%	3,321,333
Salamon Steven A J			9.4%	3,254,667
Aharon Gil			9.4%	3,188,001
Rosalind Master Fund L.P.			9.2%	3,188,001
Talphera, Inc. 13G/A Amendment 4 TLPH · 00444T209	TLPH	00444T209	9.9%	12,913,182	13G/A Amendment 4	8/12/2026 Event 6/30/2026
Rosalind Advisors, Inc.			9.9%	12,913,182
Salamon Steven A J			9.9%	12,913,182
Aharon Gil			9.9%	12,913,182
Rosalind Master Fund L.P.			9.9%	12,913,182
Biofrontera Inc. 13G/A Amendment 9 BFRI · 09077D209	BFRI	09077D209	9.9%	16,801,629	13G/A Amendment 9	8/12/2026 Event 6/30/2026
Rosalind Advisors, Inc.			9.9%	16,801,629
Salamon Steven A J			9.9%	16,801,629
Aharon Gil			9.9%	16,801,629
Rosalind Master Fund L.P.			9.9%	16,801,629
PolyPid Ltd. 13G/A Amendment 8 PYPD · M8001Q126	PYPD	M8001Q126	9.9%	5,124,011	13G/A Amendment 8	8/12/2026 Event 7/31/2026
Rosalind Advisors, Inc.			9.9%	5,124,011
Salamon Steven A J			9.9%	5,124,011
Aharon Gil			9.9%	5,124,011
Rosalind Master Fund L.P.			9.9%	5,124,011
Myomo, Inc. 13G/A Amendment 12 MYO · 62857J201	MYO	62857J201	9.9%	7,401,144	13G/A Amendment 12	8/12/2026 Event 6/30/2026
Rosalind Advisors, Inc.			9.9%	7,401,144
Salamon Steven A J			9.9%	7,401,144
Aharon Gil			9.9%	7,401,144
Rosalind Master Fund L.P.			9.9%	7,401,144
Fennec Pharmaceuticals Inc. 13G/A Amendment 2 FENC · 31447P100	FENC	31447P100	8.8%	3,041,533	13G/A Amendment 2	5/14/2026 Event 3/31/2026
Rosalind Advisors, Inc.			8.8%	3,041,533
Salamon Steven A J			8.6%	2,974,867
Aharon Gil			8.6%	2,974,867
Rosalind Master Fund L.P.			8.4%	2,908,201
Talphera, Inc. 13G/A Amendment 3 TLPH · 00444T209	TLPH	00444T209	9.9%	12,925,597	13G/A Amendment 3	5/12/2026 Event 3/31/2025
Rosalind Advisors, Inc.			9.9%	12,925,597
Salamon Steven A J			9.9%	12,925,597
Aharon Gil			9.9%	12,925,597
Rosalind Master Fund L.P.			9.9%	12,925,597
PolyPid Ltd. 13G/A Amendment 7 PYPD · M8001Q126	PYPD	M8001Q126	9.9%	5,384,813	13G/A Amendment 7	5/12/2026 Event 3/31/2026
Rosalind Advisors, Inc.			9.9%	5,384,813
Salamon Steven A J			9.9%	5,384,813
Aharon Gil			9.9%	5,384,813
Rosalind Master Fund L.P.			9.9%	5,384,813
Kiora Pharmaceuticals Inc 13G/A Amendment 3 KPRX · 49721T101	KPRX	49721T101	9.9%	464,676	13G/A Amendment 3	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.			9.9%	464,676
Salamon Steven A J			9.9%	464,676
Aharon Gil			9.9%	464,676
Rosalind Master Fund L.P.			9.9%	464,676
Fennec Pharmaceuticals Inc. 13G/A Amendment 1 FENC · 31447P100	FENC	31447P100	9.8%	2,746,840	13G/A Amendment 1	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.			9.8%	2,746,840
Salamon Steven A J			9.5%	2,680,174
Aharon Gil			9.5%	2,680,174
Rosalind Master Fund L.P.			9.3%	2,613,508
MediWound Ltd. 13G/A Amendment 9 MDWD · M68830104	MDWD	M68830104	7.0%	912,319	13G/A Amendment 9	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.			7.0%	912,319
Salamon Steven A J			7.0%	912,319
Aharon Gil			7.0%	912,319
Rosalind Master Fund L.P.			7.0%	912,319
PolyPid Ltd. 13G/A Amendment 6 PYPD · M8001Q126	PYPD	M8001Q126	9.9%	5,483,443	13G/A Amendment 6	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.			9.9%	5,483,443
Salamon Steven A J			9.9%	5,483,443
Aharon Gil			9.9%	5,483,443
Rosalind Master Fund L.P.			9.9%	5,483,443
InspireMD, Inc. 13G/A Amendment 9 NSPR · 45779A846	NSPR	45779A846	9.2%	10,987,104	13G/A Amendment 9	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.			9.2%	10,987,104
Salamon Steven A J			9.2%	10,987,104
Aharon Gil			9.2%	10,987,104
Rosalind Master Fund L.P.			8.3%	9,485,697
Rosalind Opportunities Fund I L.P.			1.0%	1,501,407
Biofrontera Inc. 13G/A Amendment 8 BFRI · 09077D209	BFRI	09077D209	9.9%	16,188,781	13G/A Amendment 8	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.			9.9%	16,188,781
Salamon Steven A J			9.9%	16,188,781
Aharon Gil			9.9%	16,188,781
Rosalind Master Fund L.P.			9.9%	16,188,781
Talphera, Inc. 13G/A Amendment 2 TLPH · 00444T209	TLPH	00444T209	9.9%	13,150,954	13G/A Amendment 2	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.			9.9%	13,150,954
Salamon Steven A J			9.9%	13,150,954
Aharon Gil			9.9%	13,150,954
Rosalind Master Fund L.P.			9.9%	13,150,954
Myomo, Inc. 13G/A Amendment 11 MYO · 62857J201	MYO	62857J201	9.9%	7,603,030	13G/A Amendment 11	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.			9.9%	7,603,030
Salamon Steven A J			9.9%	7,603,030
Aharon Gil			9.9%	7,603,030
Rosalind Master Fund L.P.			9.9%	7,603,030
Cellectar Biosciences, Inc. 13G/A Amendment 9 CLRB · 15117F500	CLRB	15117F500	5.5%	247,715	13G/A Amendment 9	2/10/2026 Event 12/31/2025
Rosalind Advisors, Inc.			5.5%	247,715
Salamon Steven A J			5.5%	247,715
Aharon Gil			5.5%	247,715
Rosalind Master Fund L.P.			4.1%	185,036
Rosalind Opportunities Fund I L.P.			1.4%	62,678
Delcath Systems, Inc. 13D/A Amendment 15 DCTH · 24661P807	DCTH	24661P807	9.9%	6,719,993	13D/A Amendment 15	2/10/2026 Event 12/31/2025
Rosalind Advisors, Inc.			9.9%	6,719,993
Salamon Steven A J			9.9%
Aharon Gil			9.9%
Rosalind Master Fund L.P.			4.4%	2,871,335
Rosalind Opportunities Fund I L.P.			4.9%	3,530,215
Fennec Pharmaceuticals Inc. 13G FENC · 31447P100	FENC	31447P100	7.5%	2,076,840	13G	11/13/2025 Event 9/30/2025
Rosalind Advisors, Inc.			7.5%	2,076,840
Salamon Steven A J			7.5%	2,076,840
Aharon Gil			7.5%	2,076,840
Rosalind Master Fund L.P.			7.5%	2,076,840
Talphera, Inc. 13G/A Amendment 1 TLPH · 00444T209	TLPH	00444T209	9.9%	13,957,438	13G/A Amendment 1	11/13/2025 Event 9/30/2025
Rosalind Advisors, Inc.			9.9%	13,957,438
Salamon Steven A J			9.9%	13,957,438
Aharon Gil			9.9%	13,957,438
Rosalind Master Fund L.P.			9.9%	13,957,438
Biofrontera Inc. 13G/A Amendment 7 BFRI · 09077D209	BFRI	09077D209	9.9%	16,777,017	13G/A Amendment 7	11/12/2025 Event 10/27/2025
Rosalind Advisors, Inc.			9.9%	16,777,017
Salamon Steven A J			9.9%	16,777,017
Aharon Gil			9.9%	16,777,017
Rosalind Master Fund L.P.			9.9%	16,777,017
PolyPid Ltd. 13G/A Amendment 5 PYPD · M8001Q126	PYPD	M8001Q126	9.9%	5,705,555	13G/A Amendment 5	11/12/2025 Event 9/30/2025
Rosalind Advisors, Inc.			9.9%	5,705,555
Salamon Steven A J			9.9%	5,705,555
Aharon Gil			9.9%	5,705,555
Rosalind Master Fund L.P.			9.9%	5,705,555
MediWound Ltd. 13G/A Amendment 8 MDWD · M68830104	MDWD	M68830104	7.0%	912,319	13G/A Amendment 8	11/12/2025 Event 9/30/2025
Rosalind Advisors, Inc.			7.0%	912,319
Salamon Steven A J			7.0%	912,319
Aharon Gil			7.0%	912,319
Rosalind Master Fund L.P.			7.0%	912,319
Myomo, Inc. 13G/A Amendment 10 MYO · 62857J201	MYO	62857J201	9.9%	7,554,046	13G/A Amendment 10	11/12/2025 Event 9/30/2025
Rosalind Advisors, Inc.			9.9%	7,554,046
Salamon Steven A J			9.9%	7,554,046
Aharon Gil			9.9%	7,554,046
Rosalind Master Fund L.P.			9.9%	7,554,046
PolyPid Ltd. 13G/A Amendment 4 PYPD · M8001Q126	PYPD	M8001Q126	9.9%	5,762,349	13G/A Amendment 4	8/13/2025 Event 6/30/2025
Rosalind Advisors, Inc.			9.9%	5,762,349
Salamon Steven A J			9.9%	5,762,349
Aharon Gil			9.9%	5,762,349
Rosalind Master Fund L.P.			9.9%	5,762,349
Kiora Pharmaceuticals Inc 13G/A Amendment 2 KPRX · 49721T101	KPRX	49721T101	9.9%	464,676	13G/A Amendment 2	8/13/2025 Event 6/30/2025
Rosalind Advisors, Inc.			9.9%	464,676
Salamon Steven A J			9.9%	464,676
Aharon Gil			9.9%	464,676
Rosalind Master Fund L.P.			9.9%	464,676
MediWound Ltd. 13G/A Amendment 7 MDWD · M68830104	MDWD	M68830104	5.2%	570,326	13G/A Amendment 7	8/12/2025 Event 6/30/2025
Rosalind Advisors, Inc.			5.2%	570,326
Salamon Steven A J			5.2%	570,326
Aharon Gil			5.2%	570,326
Rosalind Master Fund L.P.			5.2%	570,326
OptiNose, Inc. 13G/A Amendment 8 OPTN · 68404V209	OPTN	68404V209	0%	0	13G/A Amendment 8	8/11/2025 Event 6/30/2025
Rosalind Advisors, Inc.			0%	0
Salamon Steven A J			0%	0
Aharon Gil			0%	0
Rosalind Master Fund L.P.			0%	0
Myomo, Inc. 13G/A Amendment 9 MYO · 62857J201	MYO	62857J201	9.9%	7,359,046	13G/A Amendment 9	8/11/2025 Event 6/30/2025
Rosalind Advisors, Inc.			9.9%	7,359,046
Salamon Steven A J			9.9%	7,359,046
Aharon Gil			9.9%	7,359,046
Rosalind Master Fund L.P.			9.9%	7,359,046
InspireMD, Inc. 13G/A Amendment 8 NSPR · 45779A846	NSPR	45779A846	9.9%	10,987,104	13G/A Amendment 8	8/11/2025 Event 8/1/2025
Rosalind Advisors, Inc.			9.9%	10,987,104
Salamon Steven A J			9.9%	10,987,104
Aharon Gil			9.9%	10,987,104
Rosalind Master Fund L.P.			9.9%	9,485,697
Rosalind Opportunities Fund I L.P.			3.5%	1,501,407
Biofrontera Inc. 13G/A Amendment 6 BFRI · 09077D209	BFRI	09077D209	9.9%	14,432,072	13G/A Amendment 6	8/11/2025 Event 6/30/2025
Rosalind Advisors, Inc.			9.9%	14,432,072
Salamon Steven A J			9.9%	14,432,072
Aharon Gil			9.9%	14,432,072
Rosalind Master Fund L.P.			9.9%	14,432,072
InspireMD, Inc. 13G/A Amendment 8 NSPR · 45779A846	NSPR	45779A846	9.4%	10,987,104	13G/A Amendment 8	8/11/2025 Event 8/1/2025
Rosalind Advisors, Inc.			9.4%	10,987,104
Salamon Steven A J			9.4%	10,987,104
Aharon Gil			9.4%	10,987,104
Rosalind Master Fund L.P.			8.4%	9,485,697
Rosalind Opportunities Fund I L.P.			0.1%	1,501,407
InspireMD, Inc. 13G/A Amendment 8 NSPR · 45779A846	NSPR	45779A846	9.4%	10,987,104	13G/A Amendment 8	8/11/2025 Event 3/31/2025
Rosalind Advisors, Inc.			9.4%	10,987,104
Salamon Steven A J			9.4%	10,987,104
Aharon Gil			9.4%	10,987,104
Rosalind Master Fund L.P.			8.4%	9,485,697
Rosalind Opportunities Fund I L.P.			0.1%	1,501,407
Biofrontera Inc. 13G/A Amendment 5 BFRI · 09077D209	BFRI	09077D209	9.9%	9,886,969	13G/A Amendment 5	5/13/2025 Event 3/31/2025
Rosalind Advisors, Inc.			9.9%	9,886,969
Salamon Steven A J			9.9%	9,886,969
Aharon Gil			9.9%	9,886,969
Rosalind Master Fund L.P.			9.9%	9,886,969
MediWound Ltd. 13G/A Amendment 6 MDWD · M68830104	MDWD	M68830104	6.1%	670,158	13G/A Amendment 6	5/12/2025 Event 3/31/2025
Rosalind Advisors, Inc.			6.1%	670,158
Salamon Steven A J			6.1%	670,158
Aharon Gil			6.1%	670,158
Rosalind Master Fund L.P.			6.1%	670,158
OptiNose, Inc. 13G/A Amendment 7 OPTN · 68404V209	OPTN	68404V209	2.5%	343,781	13G/A Amendment 7	5/12/2025 Event 3/31/2025
Rosalind Advisors, Inc.			2.5%	343,781
Salamon Steven A J			2.5%	343,781
Aharon Gil			2.5%	343,781
Rosalind Master Fund L.P.			2.5%	343,781
InspireMD, Inc. 13G/A Amendment 7 NSPR · 45779A846	NSPR	45779A846	7.7%	9,713,171	13G/A Amendment 7	5/12/2025 Event 3/31/2025
Rosalind Advisors, Inc.			7.7%	9,713,171
Salamon Steven A J			7.7%	9,713,171
Aharon Gil			7.7%	9,713,171
Rosalind Master Fund L.P.			5.8%	8,057,171
Rosalind Opportunities Fund I L.P.			1.9%	1,656,000
Myomo, Inc. 13G/A Amendment 8 MYO · 62857J201	MYO	62857J201	9.9%	7,279,046	13G/A Amendment 8	5/12/2025 Event 3/31/2025
Rosalind Advisors, Inc.			9.9%	7,279,046
Salamon Steven A J			9.9%	7,279,046
Aharon Gil			9.9%	7,279,046
Rosalind Master Fund L.P.			9.9%	7,279,046
Delcath Systems, Inc. 13D/A Amendment 14 DCTH · 24661P807	DCTH	24661P807	9.9%	6,674,993	13D/A Amendment 14	5/12/2025 Event 5/5/2025
Rosalind Advisors, Inc.			9.9%	6,674,993
Salamon Steven A J			9.9%
Aharon Gil			9.9%
Rosalind Master Fund L.P.			4.5%	2,871,335
Rosalind Opportunities Fund I L.P.			5.0%	3,530,215
Talphera, Inc. 13G TLPH · 00444T209	TLPH	00444T209	9.9%	7,642,515	13G	4/11/2025 Event 3/31/2025
Rosalind Advisors, Inc.			9.9%	7,642,515
Salamon Steven A J			9.9%	7,642,515
Aharon Gil			9.9%	7,642,515
Rosalind Master Fund L.P.			9.9%	7,642,515
PolyPid Ltd. 13G/A Amendment 3 PYPD · M8001Q126	PYPD	M8001Q126	9.9%	4,081,088	13G/A Amendment 3	2/14/2025 Event 12/31/2024
Rosalind Advisors, Inc.			9.9%	4,081,088
Salamon Steven A J			9.9%	4,081,088
Aharon Gil			9.9%	4,081,088
Rosalind Master Fund L.P.			9.9%	4,081,088
Trevi Therapeutics, Inc. 13G/A Amendment 4 TRVI · 89532M101	TRVI	89532M101	1.2%	1,062,500	13G/A Amendment 4	2/13/2025 Event 2/13/2025
Rosalind Advisors, Inc.			1.2%	1,062,500
Salamon Steven A J			1.2%	1,062,500
Aharon Gil			1.2%	1,062,500
Rosalind Master Fund L.P.			1.2%	1,062,500
Spruce Biosciences, Inc. 13G/A Amendment 3 SPRB · 85209E109	SPRB	85209E109	0%	0	13G/A Amendment 3	2/13/2025 Event 12/31/2024
Rosalind Advisors, Inc.			0%	0
Salamon Steven A J			0%	0
Aharon Gil			0%	0
Rosalind Master Fund L.P.			0%	0
Biofrontera Inc. 13G/A Amendment 4 BFRI · 09077D209	BFRI	09077D209	9.9%	9,962,649	13G/A Amendment 4	2/12/2025 Event 12/31/2024
Rosalind Advisors, Inc.			9.9%	9,962,649
Salamon Steven A J			9.9%	9,962,649
Aharon Gil			9.9%	9,962,649
Rosalind Master Fund L.P.			9.9%	9,962,649
MediWound Ltd. 13G/A Amendment 5 MDWD · M68830104	MDWD	M68830104	7.2%	791,315	13G/A Amendment 5	2/11/2025 Event 12/31/2024
Rosalind Advisors, Inc.			7.2%	791,315
Salamon Steven A J			7.2%	791,315
Aharon Gil			7.2%	791,315
Rosalind Master Fund L.P.			7.2%	791,315
PolyPid Ltd. 13G/A Amendment 3 PYPD · M8001Q126	PYPD	M8001Q126	9.9%	4,085,588	13G/A Amendment 3	2/10/2025 Event 12/31/2024
Rosalind Advisors, Inc.			9.9%	4,085,588
Salamon Steven A J			9.9%	4,085,588
Aharon Gil			9.9%	4,085,588
Rosalind Master Fund L.P.			9.9%	4,085,588
Kiora Pharmaceuticals Inc 13G/A Amendment 1 KPRX · 49721T101	KPRX	49721T101	9.9%	715,231	13G/A Amendment 1	2/10/2025 Event 12/31/2024
Rosalind Advisors, Inc.			9.9%	715,231
Salamon Steven A J			9.9%	715,231
Aharon Gil			9.9%	715,231
Rosalind Master Fund L.P.			9.9%	715,231
OptiNose, Inc. 13G/A Amendment 6 OPTN · 68404V209	OPTN	68404V209	8.7%	964,587	13G/A Amendment 6	2/7/2025 Event 12/31/2024
Rosalind Advisors, Inc.			8.7%	964,587
Salamon Steven A J			8.7%	964,587
Aharon Gil			8.7%	964,587
Rosalind Master Fund L.P.			8.7%	964,587
InspireMD, Inc. 13G/A Amendment 6 NSPR · 45779A846	NSPR	45779A846	9.9%	9,933,964	13G/A Amendment 6	2/7/2025 Event 12/31/2024
Rosalind Advisors, Inc.			9.9%	9,933,964
Salamon Steven A J			9.9%	9,933,964
Aharon Gil			9.9%	9,933,964
Rosalind Master Fund L.P.			9.9%	8,277,964
Rosalind Opportunities Fund I L.P.			2.1%	1,656,000
Myomo, Inc. 13G/A Amendment 7 MYO · 62857J201	MYO	62857J201	9.9%	7,574,330	13G/A Amendment 7	2/4/2025 Event 12/31/2024
Rosalind Advisors, Inc.			9.9%	7,574,330
Salamon Steven A J			9.9%	7,574,330
Aharon Gil			9.9%	7,574,330
Rosalind Master Fund L.P.			9.9%	7,574,330
Cellectar Biosciences, Inc. 13G/A Amendment 8 CLRB · 15117F500	CLRB	15117F500	9.9%	7,472,745	13G/A Amendment 8	2/3/2025 Event 12/31/2024
Rosalind Advisors, Inc.			9.9%	7,472,745
Salamon Steven A J			9.9%	7,472,745
Aharon Gil			9.9%	7,472,745
Rosalind Master Fund L.P.			7.7%	5,592,395
Rosalind Opportunities Fund I L.P.			2.6%	1,880,350
Delcath Systems, Inc. 13D/A Amendment 13 DCTH · 24661P807	DCTH	24661P807	9.9%	6,659,993	13D/A Amendment 13	1/27/2025 Event 12/23/2024
Rosalind Advisors, Inc.			9.9%	6,659,993
Salamon Steven A J			9.9%
Aharon Gil			9.9%
Rosalind Master Fund L.P.			4.7%	2,871,335.33
Rosalind Opportunities Fund I L.P.			4.0%	3,530,215